Search This Blog

Thursday, February 21, 2019

Opiant Pharmaceuticals study does not meet primary endpoint

https://thefly.com/landingPageNews.php?id=2868121
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)